PRNewswire 10-Aug-2018 2:56 PM
NEW YORK, Aug. 10, 2018
NEW YORK, Aug. 10, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE American: AMPE). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/ampe.
The investigation concerns whether Ampio and certain of its officers and/or directors have violated federal securities laws.
On August 7, 2018, after-market hours, Ampio filed a Form 8-K with the SEC with a regulatory update on the FDA's review of Ampion, including the AP-003-A and AP-003-C trials. The Company revealed that it met with the FDA in July 2018 and received a response letter which stated that "as a single trial[,] the AP-003-A study alone does not appear to provide sufficient evidence of effectiveness to support [the Biologics License Application]," and that "the FDA does not consider the AP-003-C trial to be an adequate and well-controlled clinical trial." Following this news, Ampio stock dropped during intraday trading on August 8, 2018.
If you are aware of any facts relating to this investigation, or purchased Ampio shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/ampe. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | firstname.lastname@example.org
View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-ampio-pharmaceuticals-inc-ampe-300695553.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
Limited Time Offer:
Claim your free copy of income expert Bryan Perry's new report:
My Top Monthly Dividend Payer (8% Dividend Yield)
You'll also receive Bryan Perry's weekly e-letter, Dividend Investing Weekly, at no cost, along with other associated financial content and special offers.